Jul. 15 at 6:06 PM
$CRVO The stock market doesn't care but, research paper released regard young on-set dementia (before age of 65). Drugs like Neflamapimod if avaiable on the market could be a game changer for these families.
Conclusion:
Families affected by young-onset dementia navigate an intricate landscape of financial strain, safety vulnerabilities, and social isolation, magnifying the psychosocial stressors experienced by all families living with dementia. These pressures extend far beyond medical management to encompass every dimension of family life. Effective intervention requires clinicians, support organizations, and policymakers to recognize YOD as a family condition rather than an individual diagnosis—one that demands interprofessional coordination, workplace reform, and age- and culturally-relevant psychosocial support.
(Source: https://www.nature.com/articles/s44400-026-00110-x )
